JP2002068993A - Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic - Google Patents
Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmeticInfo
- Publication number
- JP2002068993A JP2002068993A JP2000260835A JP2000260835A JP2002068993A JP 2002068993 A JP2002068993 A JP 2002068993A JP 2000260835 A JP2000260835 A JP 2000260835A JP 2000260835 A JP2000260835 A JP 2000260835A JP 2002068993 A JP2002068993 A JP 2002068993A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- epidermal
- skin
- keratinizing
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 39
- 235000013305 food Nutrition 0.000 title claims abstract description 28
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 12
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 40
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 39
- 210000003491 skin Anatomy 0.000 claims abstract description 34
- 239000000284 extract Substances 0.000 claims description 67
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 37
- 230000035755 proliferation Effects 0.000 claims description 24
- 210000005175 epidermal keratinocyte Anatomy 0.000 claims description 20
- 230000001737 promoting effect Effects 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 25
- 239000000203 mixture Substances 0.000 abstract description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 23
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 abstract description 18
- 229940058015 1,3-butylene glycol Drugs 0.000 abstract description 9
- 235000019437 butane-1,3-diol Nutrition 0.000 abstract description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 5
- 239000006210 lotion Substances 0.000 abstract description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 4
- 239000006071 cream Substances 0.000 abstract description 4
- 210000002615 epidermis Anatomy 0.000 abstract description 4
- 239000002798 polar solvent Substances 0.000 abstract description 4
- 210000001161 mammalian embryo Anatomy 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 235000013361 beverage Nutrition 0.000 abstract description 2
- 235000009508 confectionery Nutrition 0.000 abstract description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 1
- 235000005807 Nelumbo Nutrition 0.000 abstract 1
- 210000002510 keratinocyte Anatomy 0.000 description 16
- 238000009472 formulation Methods 0.000 description 11
- 235000015872 dietary supplement Nutrition 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 210000000434 stratum corneum Anatomy 0.000 description 9
- 230000036541 health Effects 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- -1 aliphatic alcohols Chemical class 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 230000003780 keratinization Effects 0.000 description 3
- 229940069445 licorice extract Drugs 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000003531 protein hydrolysate Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229950004959 sorbitan oleate Drugs 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000219780 Pueraria Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N beta-Carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 235000020710 ginseng extract Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000036074 healthy skin Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XZEUYTKSAYNYPK-UHFFFAOYSA-N 3beta-29-Norcycloart-24-en-3-ol Natural products C1CC2(C)C(C(CCC=C(C)C)C)CCC2(C)C2CCC3C(C)C(O)CCC33C21C3 XZEUYTKSAYNYPK-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 244000026811 Brassica nipposinica Species 0.000 description 1
- 235000007294 Brassica nipposinica Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- RRTBTJPVUGMUNR-UHFFFAOYSA-N Cycloartanol Natural products C12CCC(C(C(O)CC3)(C)C)C3C2(CC)CCC2(C)C1(C)CCC2C(C)CCCC(C)C RRTBTJPVUGMUNR-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 1
- HVXLSFNCWWWDPA-UHFFFAOYSA-N Isocycloartenol Natural products C1CC(O)C(C)(C)C2C31CC13CCC3(C)C(C(CCCC(C)=C)C)CCC3(C)C1CC2 HVXLSFNCWWWDPA-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000007189 Oryza longistaminata Nutrition 0.000 description 1
- HXQRIQXPGMPSRW-UHZRDUGNSA-N Pollinastanol Natural products O[C@@H]1C[C@H]2[C@@]3([C@]4([C@H]([C@@]5(C)[C@@](C)([C@H]([C@H](CCCC(C)C)C)CC5)CC4)CC2)C3)CC1 HXQRIQXPGMPSRW-UHZRDUGNSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 241001237745 Salamis Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- 125000003042 alpha-carotene group Chemical group 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 235000019216 blueberry extract Nutrition 0.000 description 1
- XPXZDHXJQITWQI-UHFFFAOYSA-N butane-1,3-diol;hydrate Chemical compound O.CC(O)CCO XPXZDHXJQITWQI-UHFFFAOYSA-N 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- YNBJLDSWFGUFRT-UHFFFAOYSA-N cycloartenol Natural products CC(CCC=C(C)C)C1CCC2(C)C1(C)CCC34CC35CCC(O)C(C)(C)C5CCC24C YNBJLDSWFGUFRT-UHFFFAOYSA-N 0.000 description 1
- FODTZLFLDFKIQH-UHFFFAOYSA-N cycloartenol trans-ferulate Natural products C1=C(O)C(OC)=CC(C=CC(=O)OC2C(C3CCC4C5(C)CCC(C5(C)CCC54CC53CC2)C(C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 1
- JLYXXMFPNIAWKQ-UHFFFAOYSA-N gamma-hexachlorocyclohexane Natural products ClC1C(Cl)C(Cl)C(Cl)C(Cl)C1Cl JLYXXMFPNIAWKQ-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000015201 grapefruit juice Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 229960002809 lindane Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000013525 pomegranate juice Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000015175 salami Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Confectionery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は表皮角化細胞増殖促
進剤及び美容用食品並びに皮膚化粧料に関する。具体的
には、特にヒトの表皮の大部分を構成する細胞である表
皮角化細胞を活発化させる表皮角化細胞増殖促進剤及び
当該表皮角化細胞増殖促進剤を利用した美容用食品並び
に皮膚化粧料に関する。TECHNICAL FIELD The present invention relates to an epidermal keratinocyte proliferation promoter, a cosmetic food, and a skin cosmetic. Specifically, an epidermal keratinocyte proliferation promoter that activates keratinocytes, which is a cell that constitutes most of the human epidermis, and a cosmetic food and skin using the keratinocyte proliferation promoter Related to cosmetics.
【0002】[0002]
【従来の技術】表皮は、最下層である基底層から始っ
て、有棘層、顆粒層、角質層へと連なる4層構造からな
るが、各層に存在する大部分の細胞は、基底層から分化
した角化細胞である。通常、角化細胞は基底層で産ま
れ、徐々に上層に分化しながら移動して角質細胞となっ
て角質層を構成し、最終的に垢として角質層から脱落し
ていく。2. Description of the Related Art The epidermis has a four-layer structure starting from the lowermost layer, the basal layer, and continuing to the spinous layer, the granular layer, and the stratum corneum. Most cells in each layer are composed of the basal layer. Keratinocytes differentiated from Normally, keratinocytes are born in the basal layer, gradually differentiate into the upper layer, migrate and become keratinocytes, constitute the stratum corneum, and finally fall off as dirt from the stratum corneum.
【0003】角質層は皮膚の最外殻に存在しており、絶
えずターンオーバーを繰り返して一定の厚さと水分量を
保持して、外界からの刺激に対するバリアー的な役割を
果たしている。皮膚ではこのバリアー機能を持たせるた
め、角化細胞が基底層で産まれてから垢となって剥がれ
落ちるまでのサイクル(角化)を通常4週間の周期で繰
り返し、表皮の新陳代謝を行っている。しかしながら、
この角質層も加齢によって新陳代謝機能が衰え、こじ
わ、くすみ、色素沈着、肌荒れ等の皮膚トラブルを発生
することになる。[0003] The stratum corneum is present in the outermost shell of the skin, and constantly turns over to maintain a certain thickness and water content, thereby serving as a barrier against external stimuli. In order to provide this barrier function in the skin, the cycle (keratinization) of keratinocytes from being born in the basal layer to becoming flaked and peeling off (keratinization) is usually repeated at a cycle of four weeks, thereby performing metabolism of the epidermis. However,
The metabolic function of the stratum corneum also deteriorates due to aging, and skin troubles such as wrinkles, dullness, pigmentation, and rough skin occur.
【0004】従来、切り傷の治療、火傷等のひび割れ、
あかぎれ、ただれなどの創傷治癒促進あるいはこじわ、
くすみ、色素沈着、肌荒れ等の皮膚老化防止、細胞賦活
などを目的として、皮膚化粧料中にヒアルロン酸、アラ
ントイン及びその誘導体、牛血球除去蛋白質、シコンエ
キス、人参エキス、プラセンタエキス等、さまざまな角
化細胞増殖促進剤が配合されている。Conventionally, treatment of cuts, cracks such as burns,
Accelerating or healing wound healing
Various keratinizations such as hyaluronic acid, allantoin and its derivatives, bovine blood cell-removing protein, sicon extract, ginseng extract, and placenta extract in skin cosmetics for the purpose of preventing skin aging such as dullness, pigmentation and rough skin, and activating cells A cell growth promoter is included.
【0005】しかしながら、症状によっては上記の薬効
成分を含む皮膚外用剤では充分な効果を得ることができ
ないため、より顕著な表皮角化細胞増殖作用を有する作
用剤が望まれていた。[0005] However, depending on the symptoms, an external preparation for skin containing the above-mentioned medicinal ingredients cannot provide a sufficient effect. Therefore, an agent having a more pronounced epidermal keratinocyte proliferation activity has been desired.
【0006】また、近年いわゆる機能性食品の有用性が
指摘されるようになっているが、角質層の機能を高める
ものは知られていない。肌の状態は健康状態と関わりが
深く、また人の健康は食生活によるところが大きい。そ
こで、食品によって皮膚角質層の機能を内側から高めて
健康な肌に導くものは極めて望ましい。したがって、人
体に安全な角質層の機能を高める機能性食品やこれを実
現させる角質層機能促進物質が望まれていた。[0006] In recent years, the usefulness of so-called functional foods has been pointed out, but nothing that enhances the function of the stratum corneum is known. Skin condition is closely related to health condition, and human health depends largely on diet. Therefore, it is highly desirable that foods enhance the function of the stratum corneum from the inside and lead to healthy skin. Therefore, a functional food that enhances the function of the stratum corneum that is safe for the human body and a stratum corneum function promoting substance that realizes this are desired.
【0007】[0007]
【発明が解決しようとする課題】そこで、本発明者ら
は、鋭意研究を重ねた結果、古来より食されあるいは漢
方薬として使用されており、その安全性が確立されてい
るハスの実の一部であるハス胚芽を用いて抽出されたハ
ス胚芽抽出物が、表皮角化細胞増殖作用を有することを
見いだし本発明を完成するに至った。The inventors of the present invention have conducted intensive studies and, as a result, have found that some of the lotus seeds that have been eaten or used as a Chinese medicine since ancient times and whose safety has been established have been established. It has been found that the lotus germ extract extracted by using the lotus germ has an epidermal keratinocyte proliferation action, and has completed the present invention.
【0008】[0008]
【課題を解決するための手段】本発明に係る表皮角化細
胞増殖促進剤は、ハス胚芽抽出物を含有することを特徴
としている。なお、本発明にいう表皮角化細胞増殖促進
剤とは、上記したように表皮角化細胞の増殖、すなわち
基底層における角化細胞の分裂を促進する作用を有する
ものであって、下記の試験法にて作用を確認することが
できる物質を意味する。Means for Solving the Problems The epidermal keratinocyte proliferation promoter according to the present invention is characterized by containing a lotus germ extract. The epidermal keratinocyte proliferation promoter referred to in the present invention has an action of promoting the proliferation of epidermal keratinocytes, that is, promoting the division of keratinocytes in the basal layer, as described above. A substance whose action can be confirmed by the law.
【0009】本発明においては、すいれん科ハス属のハ
ス(Nelumbo nucifera Gaertn.)の種子中にある胚(胚
芽)が用いられる。胚芽は、通常緑色で棒状をしてお
り、採取した種子から取り出し、生のままあるいは直ち
に乾燥したものが好適に用いられる。In the present invention, an embryo (germ) in a seed of a lotus (Nelumbo nucifera Gaertn.) Belonging to the genus Lotus of the convulsive family is used. Embryos are usually green and rod-shaped, and those that are taken out from collected seeds and dried raw or immediately dried are preferably used.
【0010】ハス胚芽抽出物は、この胚芽を水や各種の
有機溶媒、例えばメタノール、エタノール等の低級脂肪
族アルコール、アセトン、1,3−ブチレングリコール
等の極性溶媒のほかクロロホルム、酢酸エチル等の中間
極性溶媒またはこれらの混合物、さらには水とこれらの
有機溶媒との混合抽出溶媒を用いて抽出することにより
得られるものである。[0010] The lotus germ extract is prepared by adding the germ to water or various organic solvents, for example, lower aliphatic alcohols such as methanol and ethanol, polar solvents such as acetone and 1,3-butylene glycol, and chloroform and ethyl acetate. It is obtained by extraction using an intermediate polar solvent or a mixture thereof, or a mixed extraction solvent of water and these organic solvents.
【0011】抽出に際してはハス種子より得られた胚芽
をそのまま用いることもできるが、抽出効率を高めるた
め、予め粉砕して用いるのが好ましい。また、ヘキサン
などの非水系溶媒(非極性溶媒)を用いて予め脱脂処理
しておくと、不純物含量が少なくなり、より効果の高い
抽出物が得られる。In the extraction, the germ obtained from the lotus seed can be used as it is, but it is preferable to use the germ in advance in order to increase the extraction efficiency. In addition, if a non-aqueous solvent (a non-polar solvent) such as hexane is used in advance to perform a degreasing treatment, the content of impurities is reduced, and a more effective extract is obtained.
【0012】抽出は、室温ないし加熱下において、抽出
溶媒に応じて任意の装置を用いて行うことができる。例
えば、抽出溶媒を満たした処理槽に粉砕したハス胚芽を
投入し、ときどき撹拌しながら可溶性成分を溶出させ
る。その後、ろ過して抽出残渣を除去し、抽出液を得る
ことができる。このとき用いる溶媒量は、概ねハス胚芽
に対して重量比で、1:5〜1:20となるように用い
るのがよい。[0012] The extraction can be carried out at room temperature or under heating by using any apparatus depending on the extraction solvent. For example, crushed lotus germ is put into a treatment tank filled with an extraction solvent, and a soluble component is eluted with occasional stirring. Thereafter, the residue is removed by filtration to obtain an extract. It is preferable that the amount of the solvent used at this time is approximately 1: 5 to 1:20 by weight relative to the lotus germ.
【0013】こうして得られた抽出物(液)は、そのま
ま表皮角化細胞増殖促進剤として用いることも出来る
が、得られた抽出物の表皮角化細胞増殖作用が低い場合
もあり、当該作用の低下を妨げない範囲で、抽出液を濃
縮した濃縮液やさらに濃縮したエキス状物あるいは抽出
溶媒等を留去した乾燥物として提供することもできる。The extract (liquid) thus obtained can be used as it is as an agent for promoting epidermal keratinocyte proliferation. However, the extract obtained has a low epidermal keratinocyte proliferation activity in some cases. As long as the reduction is not hindered, the extract may be provided as a concentrated solution obtained by concentrating the extract, or an extract obtained by further concentrating the extract, or a dried product obtained by evaporating the extraction solvent and the like.
【0014】また、ハス胚芽の抽出物は特有のにおいと
味を有するので、その作用を低下させない程度に脱臭や
脱色等を目的として精製を行うのが好ましい。もちろ
ん、その使用目的等に応じて、例えば本発明に係る美容
用食品や皮膚化粧料に含有させる場合には、大量に使用
するものではないため、そのまま使用しても実用上差し
支えない。Since the extract of lotus germ has a unique smell and taste, it is preferable to purify the extract for the purpose of deodorizing and decoloring to the extent that its action is not reduced. Of course, depending on the purpose of use, for example, when it is contained in the cosmetic food or skin cosmetic according to the present invention, it is not used in a large amount, so that it can be used without any practical use.
【0015】さらに本発明の表皮角化細胞増殖促進剤に
は、必要に応じて上記抽出物に、保存やその取り扱いを
容易にすべく、ショ糖や乳糖などの各種糖類、たんぱく
質やデンプンなどの賦形剤、その他の任意の助剤を用い
ることにしてもよい。また、適宜、製剤化して提供する
ことも可能であって、例えば、粉末状、顆粒状、錠剤状
など任意の剤形として提供することも可能なものであ
る。Further, the epidermal keratinocyte proliferation-promoting agent of the present invention may contain various sugars such as sucrose and lactose, proteins and starch in the above-mentioned extract, if necessary, in order to facilitate storage and handling thereof. Excipients and any other auxiliaries may be used. In addition, it can be provided in the form of an appropriate formulation, and can be provided in any dosage form such as, for example, a powder, a granule, and a tablet.
【0016】当該表皮角化細胞増殖促進剤は、任意の食
品に添加することにより、あるいはこれらを主成分とし
た栄養補助食品などの美容用食品として、経口的に活用
することができる。添加可能な食品には、例えば、各種
の清涼飲料水や果汁飲料、和洋菓子、乳製品その他の畜
産加工品、果実加工品、野菜加工品、穀物の加工品、水
産加工品、調味料、ビタミンなどを主成分としたいわゆ
る各種の健康食品など数多くの飲食品が挙げられる。ま
た、栄養補助食品として、例えば、液剤の形態のものや
錠剤などの形態のものとして提供することもできる。こ
の場合の添加率は、添加対象である美容用食品の一般的
な摂取量を考慮して、液状、固形状など抽出物の形態に
よっても異なるが、概ね通常成人1日当たりのハス胚芽
抽出物摂取量として約1〜1000mg、原料であるハ
ス胚芽乾燥物に換算して、概ね3〜6000mgになる
ように添加するのが適当である。The epidermal keratinocyte proliferation promoter can be used orally by adding it to any food or as a cosmetic food such as a dietary supplement containing these as a main component. Foods that can be added include, for example, various soft drinks and fruit juice beverages, Japanese and Western confectionery, dairy products and other livestock processed products, fruit processed products, vegetable processed products, processed cereal products, processed marine products, seasonings, vitamins Numerous foods and drinks such as so-called various health foods containing as a main component. In addition, it can be provided as a dietary supplement, for example, in the form of a liquid or a tablet. In this case, the addition rate varies depending on the form of the extract such as liquid or solid, taking into account the general intake of the cosmetic food to be added, but generally the intake of the lotus germ extract per adult per day It is appropriate to add about 1 to 1000 mg in terms of the amount, which is about 3 to 6000 mg in terms of dry matter of the lotus germ as a raw material.
【0017】また、ハス胚芽抽出物の作用を最も効果的
に発揮させるためには、各種の皮膚化粧料に配合するこ
とである。配合対象として適当な皮膚化粧料は、例え
ば、軟膏、クリーム、乳液、ローション、パック、入浴
剤等であり、この場合の配合量として、ハス胚芽抽出物
として概ね0.01〜10重量%、原料であるハス胚芽
乾燥物換算として、概ね0.04〜40%になるように
添加するのが適当である。また、頭皮の健常性を保つた
めに、本発明の表皮角化細胞増殖促進剤であるハス胚芽
抽出物をトニック、リンス、育毛・養毛剤等に配合する
ことも好適である。もちろん、これらの配合量はあくま
でも目安であって、当該範囲以下であっても、それを越
えて配合することもできる。In order to exhibit the action of the lotus germ extract most effectively, it is necessary to mix it with various skin cosmetics. Skin cosmetics suitable for the formulation are, for example, ointments, creams, emulsions, lotions, packs, bath preparations and the like. In this case, the blending amount is about 0.01 to 10% by weight as a lotus germ extract, It is appropriate to add so that it becomes approximately 0.04 to 40% in terms of dry lotus germ. In order to maintain the health of the scalp, it is also preferable to mix the lotus germ extract, which is the epidermal keratinocyte proliferation promoter of the present invention, with tonics, rinses, hair growth / hair restoration agents, and the like. Needless to say, the amounts of these components are only guidelines, and even if they are less than or equal to the above range, they can be blended beyond them.
【0018】なお、本発明に係る美容用食品や皮膚化粧
料には、皮膚角化細胞増殖促進作用を妨げない限り、美
容用食品や皮膚化粧料の製造に通常用いられる各種原材
料を用いることができるのは言うまでもない。In the cosmetic food and skin cosmetic according to the present invention, various raw materials usually used in the production of cosmetic food and skin cosmetic are used as long as they do not hinder the promotion of skin keratinocyte proliferation. It goes without saying that you can do it.
【0019】また、ヒトの皮膚のみならず動物の皮膚に
おいても同様に適用することができるものであり、さら
に言えば本発明の皮膚化粧料は、単に健康な皮膚に塗布
して皮膚の老化防止などに寄与するもののみならず、切
り傷の治療、火傷等のひび割れ、あかぎれ、ただれなど
の創傷治癒促進を目的とした治療用の皮膚適用剤など、
広くヒト若しくは動物の皮膚に適用される皮膚適用剤を
意味するものである。The present invention can be applied not only to human skin but also to animal skin. In addition, the skin cosmetic of the present invention can be simply applied to healthy skin to prevent skin aging. Not only those that contribute to the treatment of cuts, cracks such as burns, irritations, skin application agents for the purpose of promoting wound healing such as soreness, etc.
It means a skin application agent widely applied to human or animal skin.
【0020】[0020]
【実施例】次に、本発明の実施例である皮膚角化細胞増
殖促進剤及び本発明の製剤例である美容用食品及び皮膚
化粧料を示し、さらに本発明について詳細に説明する。EXAMPLES Next, skin keratinocyte proliferation promoters, which are examples of the present invention, and cosmetic foods and skin cosmetics, which are formulation examples of the present invention, will be described, and the present invention will be further described in detail.
【0021】(実施例1)ハス胚芽の粗砕物300gを
表1に示す抽出溶媒2000mlにそれぞれ投入し、7
0℃に保温し、撹拌しながら2時間抽出した後、ろ紙を
用いてろ過し、抽出液を得た。この抽出液を40℃で減
圧下に濃縮し、減圧乾燥機で乾燥して、粉末状のハス胚
芽抽出物である皮膚角化細胞増殖促進剤を得た。その収
量を表1に示す。(Example 1) 300 g of the crushed lotus germ was put into 2000 ml of an extraction solvent shown in Table 1,
After keeping the temperature at 0 ° C and extracting with stirring for 2 hours, the mixture was filtered using a filter paper to obtain an extract. This extract was concentrated at 40 ° C. under reduced pressure, and dried with a vacuum drier to obtain a powdery lotus germ extract, a skin keratinocyte proliferation promoter. The yield is shown in Table 1.
【0022】[0022]
【表1】 [Table 1]
【0023】(実施例2)ハス胚芽の粗砕物300gを
1,3−ブチレングリコール・水混液(容量比1:1)
2000mlに投入して70℃に保温し、撹拌しながら
2時間抽出した後、ろ紙を用いてろ過し、抽出液を得
た。この抽出液を5℃で10日間放置し、生じた沈殿を
ケイソウ土を用いて吸引ろ過して、液状のハス胚芽抽出
物である皮膚角化細胞増殖促進剤1460mlを得た。
なお、このろ液2mlをとり重量既知のシャーレに入
れ、蒸気浴上で溶媒を蒸発させたのち105℃でさらに
乾燥させ、固形分濃度を測定・算出した結果、2.2w
/v%であった。Example 2 300 g of a lotus crushed lotus germ was mixed with 1,3-butylene glycol / water (volume ratio 1: 1).
After pouring into 2000 ml, keeping the temperature at 70 ° C., extracting for 2 hours with stirring, the mixture was filtered using a filter paper to obtain an extract. This extract was allowed to stand at 5 ° C. for 10 days, and the resulting precipitate was subjected to suction filtration using diatomaceous earth to obtain 1,460 ml of a skin lotion extract of skin keratinocytes, which is a liquid lotus embryo extract.
2 ml of the filtrate was placed in a petri dish of known weight, the solvent was evaporated on a steam bath, and further dried at 105 ° C., and the solid content concentration was measured and calculated.
/ V%.
【0024】次に実施例1で得た各種皮膚角化細胞増殖
促進剤を用いて、本発明に係る美容用食品及び皮膚化粧
料を各種作製した。 (製剤例1) 〔錠剤状美容用食品〕 ハス胚芽 エタノール・水混液(1:1)抽出物 100(重量部) コラーゲン 30 ムコ多糖・タンパク(コンドロイチン) 10 ヒアルロン酸 1 月桃葉茎抽出物 33 黒米抽出物(ポリフェノールを含む) 33 甘草抽出物(グリチルリチンを含む) 10 ミルク蛋白加水分解物 (アミノ酸、低分子ペプチドを含む) 10 ビタミンB群混合粉末(全ビタミンB群を含む) 4 ビタミンC 10 粉糖(ショ糖) 47 グリセリン脂肪酸エステル 12 上記成分分量を取り、常法に従って本発明に係る美容用
食品である錠剤状の健康・栄養補助食品を製造した。Next, using the various skin keratinocyte proliferation promoters obtained in Example 1, various cosmetic foods and skin cosmetics according to the present invention were prepared. (Formulation Example 1) [Tablet Beauty Food] Lotus Germ Ethanol / Water Mixture (1: 1) Extract 100 (parts by weight) Collagen 30 Mucopolysaccharide / Protein (Chondroitin) 10 Hyaluronic Acid January Pink Peach Extract 33 Black Rice Extract (including polyphenols) 33 Licorice extract (including glycyrrhizin) 10 Milk protein hydrolyzate (including amino acids and low molecular peptides) 10 Vitamin B group mixed powder (including all vitamin B groups) 4 Vitamin C 10 powder Sugar (sucrose) 47 Glycerin fatty acid ester 12 The above component amounts were taken, and a tablet-shaped health and nutritional supplement, which is a cosmetic food according to the present invention, was produced according to a conventional method.
【0025】 (製剤例2) 〔顆粒状美容用食品〕 ハス胚芽水抽出物 200(重量部) 真珠蛋白加水分解物(各種アミノ酸、ペプチドを含む) 15 シルク蛋白加水分解物 15 大豆イソフラボン 10 紫米抽出物(ポリフェノールを含む) 100 赤ワインエキスパウダー(プロシアニジンを含む) 30 酵母エキス (グルタチオン、核酸、アミノ酸、ビタミンを含む) 10 ザクロ種子抽出物 10 小麦胚芽抽出物 (ビタミン、クロム、セレン、モリブデンを含む) 10 DNA 30 ビートオリゴ糖 1060 ステビア抽出物 10 上記成分分量を取り、常法に従って本発明に係る美容用
食品である顆粒状の健康・栄養補助食品を製造した。(Formulation Example 2) [Granular cosmetic food] Lotus germ water extract 200 (parts by weight) Pearl protein hydrolyzate (including various amino acids and peptides) 15 Silk protein hydrolyzate 15 Soy isoflavone 10 Purple rice Extract (including polyphenols) 100 Red wine extract powder (including procyanidin) 30 Yeast extract (including glutathione, nucleic acids, amino acids, and vitamins) 10 Pomegranate seed extract 10 Wheat germ extract (including vitamins, chromium, selenium, and molybdenum) 10) DNA 30 Beet oligosaccharide 1060 Stevia extract 10 The above component amounts were taken, and a granular health and nutritional supplement, which is a cosmetic food according to the present invention, was produced according to a conventional method.
【0026】 (製剤例3) 〔カプセル状美容用食品〕 ハス胚芽 エタノール・水混液(1:1)抽出物 50(重量部) セラミド 30 リン脂質(レシチン) 10 ビタミンE(トコフェロール) 17 マルチカロチン (α及びβカロチン、ルテイン、リコペン) 10 赤米抽出物(シクロアルテノールエステルを含む) 33 オクタコサノール 1 植物ステロール 5 シソの実油(α−リノレン酸を含む) 20 精製魚油(DHA、EPAを含む) 20 ごま油(リグナン化合物を含む) 20 オリーブ油 10 大豆、なたね混合油 62 グリセリン脂肪酸エステル 12 上記成分分量を取り、常法に従ってゼラチンカプセル化
し、本発明に係る美容用食品であるカプセル状の健康・
栄養補助食品を製造した。(Formulation Example 3) [Capsule-shaped cosmetic food] Lotus germ Ethanol / water mixture (1: 1) extract 50 (parts by weight) Ceramide 30 Phospholipid (lecithin) 10 Vitamin E (tocopherol) 17 Multicarotene ( α and β carotene, lutein, lycopene 10 red rice extract (including cycloartenol ester) 33 octacosanol 1 plant sterol 5 perilla seed oil (including α-linolenic acid) 20 purified fish oil (including DHA, EPA) REFERENCE SIGNS LIST 20 Sesame oil (including lignan compound) 20 Olive oil 10 Soybean and rapeseed mixed oil 62 Glycerin fatty acid ester 12 Take the above component amounts, gelatin capsule according to a conventional method, and obtain capsule-shaped health and beauty food according to the present invention.
Dietary supplements were manufactured.
【0027】 (製剤例4) 〔清涼飲料水状美容用食品 100重量部中〕 ハス胚芽水抽出物 1(重量部) ローヤルゼリー 3 水溶性コラーゲン 8 ハトムギエキス 1 高麗ニンジンエキス(サポニンを含む) 1 プラセンタエキス 1 プエラリアエキス(フラボノイドを含む) 1 パープルヤムエキス 1 オリゴ糖 5 ショ糖 10 プルーン果汁 2 ザクロ果汁 5 グレープフルーツ果汁 10 ビタミンC 1 グレープフルーツフレーバー 0.7 水 残 量 上記成分分量を取り、撹拌溶解して、本発明に係る美容
用食品である清涼飲料水状の健康・栄養補助食品を製造
した。(Formulation Example 4) [In 100 parts by weight of soft drink aqueous cosmetic food] Lotus germ water extract 1 (parts by weight) Royal jelly 3 Water-soluble collagen 8 Barley extract 1 Ginseng extract (including saponin) 1 Placenta Extract 1 Pueraria extract (including flavonoids) 1 Purple yam extract 1 Oligosaccharide 5 Sucrose 10 Prune juice 2 Pomegranate juice 5 Grapefruit juice 10 Vitamin C 1 Grapefruit flavor 0.7 Water balance Take the above component amounts, stir and dissolve A soft drink-like health / dietary supplement, which is a cosmetic food according to the present invention, was produced.
【0028】 (製剤例5) 〔キャンディ状美容用食品〕 ハス胚芽 エタノール・水混液(1:1)抽出物 2(重量部) 水あめ 30 甘草エキス 3 甜茶エキス 1 ブルーベリーエキス(アントシアンを含む) 1 緑茶エキス(植物ポリフェノールを含む) 3 ストロベリー1/5濃縮果汁 1 赤キャベツ色素 0.05 レモン果汁 0.5 水 5 上記成分分量を取り、常法に従って本発明に係る美容用
食品であるキャンディ状の健康・栄養補助食品を製造し
た。(Formulation Example 5) [Candy-like cosmetic food] Lotus germ Ethanol / water mixture (1: 1) extract 2 (parts by weight) Mizuna 30 Licorice extract 3 Teng tea extract 1 Blueberry extract (including anthocyan) 1 Green tea Extract (including plant polyphenols) 3 Strawberry 1/5 concentrated juice 1 Red cabbage pigment 0.05 Lemon juice 0.5 Water 5 Take the above component amounts, and according to a conventional method, candy-like health which is a cosmetic food according to the present invention. -Made dietary supplements.
【0029】 (製剤例6) 〔乳液 100ml中〕 ハス胚芽エタノール・水混液(1:1)抽出物 1.0g グリチルレチン酸ステアリル 0.2g セチルアルコール 0.5g アスコルビン酸リン酸エステルマグネシウム 3.0g ミツロウ 2.0g オレイン酸ポリオキシエチレンソルビタン(10E.O.) 1.0g モノステアリン酸グリセリル 1.0g ヒアルロン酸 0.1g プロピレングリコール 5.0g オウゴン抽出液 1.0g エンドウ種子抽出物 1.0g エタノール 3.0g パラオキシ安息香酸メチル 0.3g 香料 0.03g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料である乳液を作製した。(Formulation Example 6) [Emulsion in 100 ml] Lotus germ ethanol / water mixture (1: 1) extract 1.0 g Stearyl glycyrrhetinate 0.2 g Cetyl alcohol 0.5 g Magnesium ascorbate 3.0 g Beeswax 2.0 g Polyoxyethylene sorbitan oleate (10E.O.) 1.0 g Glyceryl monostearate 1.0 g Hyaluronic acid 0.1 g Propylene glycol 5.0 g Ogon extract 1.0 g Pea seed extract 1.0 g Ethanol 3 0.0g Methyl paraoxybenzoate 0.3g Fragrance 0.03g Remaining amount of purified water The above component amounts were taken, and an emulsion as the skin cosmetic according to the present invention was prepared according to a conventional method.
【0030】 (製剤例7) 〔乳液 100ml中〕 ハス胚芽エタノール抽出物 0.1g ハス胚芽 1,3−ブチレングリコール・水混液(1:1)抽出物 1.0g ホホバオイル 4.0g オリーブオイル 2.0g スクワラン 2.0g セタノール 2.0g 酢酸トコフェロール 0.2g モノステアリン酸グリセリル 2.0g ポリオキシエチレンセチルエーテル(20E.O.) 2.5g オレイン酸ポリオキシエチレンソルビタン(20E.O.) 2.0g 1,3−ブチレングリコール 3.0g パラオキシ安息香酸メチル 0.15g シラカバ樹皮抽出物 0.5g 油溶性甘草エキス 0.05g ケイ皮抽出物 0.5g 香料 0.05g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料である乳液を作製した。(Formulation Example 7) [Emulsion 100 ml] Lotus germ ethanol extract 0.1 g Lotus germ 1,3-butylene glycol / water mixture (1: 1) extract 1.0 g Jojoba oil 4.0 g olive oil 2 2.0 g Squalane 2.0 g Cetanol 2.0 g Tocopherol acetate 0.2 g Glyceryl monostearate 2.0 g Polyoxyethylene cetyl ether (20 EO) 2.5 g Polyoxyethylene sorbitan oleate (20 EO) 0 g 1,3-butylene glycol 3.0 g methyl paraoxybenzoate 0.15 g birch bark extract 0.5 g oil-soluble licorice extract 0.05 g cinnabar extract 0.5 g flavoring 0.05 g purified water balance Then, an emulsion as a skin cosmetic according to the present invention was prepared according to a conventional method.
【0031】 (製剤例8) 〔化粧水 100ml中〕 ハス胚芽水抽出物 0.2g ハス胚芽 1,3−ブチレングリコール・水混液(1:1)抽出物 2.0g グリセリン 3.0g 1,3−ブチレングリコール 3.0g オレイン酸ポリオキシエチレンソルビタン(20E.O.) 0.5g パラオキシ安息香酸メチル 0.15g クエン酸 0.1g クエン酸ナトリウム 0.1g グリチルリチン酸ジカリウム 0.3g リンデン抽出物 0.5g ビワ抽出物 0.5g 酵母エキス 0.3g ヒアルロン酸水溶液(固形分1%) 3.0g 香料 0.05g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料である化粧水を作製した。(Preparation Example 8) [In 100 ml of lotion] Lotus germ water extract 0.2 g Lotus germ 1,3-butylene glycol / water mixture (1: 1) extract 2.0 g glycerin 3.0 g 1,3 -Butylene glycol 3.0 g polyoxyethylene sorbitan oleate (20E.O.) 0.5 g methyl paraoxybenzoate 0.15 g citric acid 0.1 g sodium citrate 0.1 g dipotassium glycyrrhizinate 0.3 g lindane extract 0.0 5 g Loquat extract 0.5 g Yeast extract 0.3 g Hyaluronic acid aqueous solution (solid content: 1%) 3.0 g Fragrance 0.05 g Purified water balance A lotion was prepared.
【0032】 (製剤例9) 〔クリーム 100g中〕 ハス胚芽エタノール抽出物 0.1g ハス胚芽 1,3−ブチレングリコール・水混液(1:1)抽出物 1.0g ニンジン抽出液 0.2g ジユ抽出物 0.5g トルメンチラ抽出物 0.5g 加水分解コンキオリン 0.1g 流動パラフィン 5.0g 小麦セラミド 0.1g サラシミツロウ 4.0g セタノール 3.0g スクワラン 10.0g ラノリン 2.0g ステアリン酸 1.0g オレイン酸ポリオキシエチレンソルビタン(20E.O.) 1.5g モノステアリン酸グリセリル 3.0g 1,3−ブチレングリコール 6.0g パラオキシ安息香酸メチル 1.5g 香料 0.1g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料であるW/O型のクリームを作製した。(Preparation Example 9) [In 100 g of cream] Lotus extract of ethanol extract 0.1 g Lotus germ 1,3-butylene glycol-water mixture (1: 1) extract 1.0 g Carrot extract 0.2 g Extract of extract 0.5 g Tormentilla extract 0.5 g Hydrolyzed conchiolin 0.1 g Liquid paraffin 5.0 g Wheat ceramide 0.1 g Salami beeswax 4.0 g Cetanol 3.0 g Squalane 10.0 g Lanolin 2.0 g Stearic acid 1.0 g Oleic acid Polyoxyethylene sorbitan (20E.O.) 1.5 g Glyceryl monostearate 3.0 g 1,3-butylene glycol 6.0 g Methyl parahydroxybenzoate 1.5 g Fragrance 0.1 g Purified water balance A W / O type cream, which is a skin cosmetic according to the present invention, is prepared according to a conventional method. It was.
【0033】 (製剤例10) 〔パック 100g中〕 ハス胚芽 1,3−ブチレングリコール・水混液(1:1)抽出物 5.0g ポリビニルアルコール 15.0g プラセンタエキス 1.0g アスコルビン酸 0.02g プエラリアエキス 0.2g オトギリソウ抽出物 1.0g ポリエチレングリコール 3.0g プロピレングリコール 7.0g エタノール 10.0g パラオキシ安息香酸メチル 0.05g 香料 0.05g 精製水 残 量 上記成分分量を取り、常法に従って本発明に係る皮膚化
粧料であるパックを作製した。(Formulation Example 10) [In 100 g of pack] Lotus germ 1,3-butylene glycol / water mixture (1: 1) extract 5.0 g Polyvinyl alcohol 15.0 g Placenta extract 1.0 g Ascorbic acid 0.02 g Pueraria Extract 0.2 g Hypericum extract 1.0 g Polyethylene glycol 3.0 g Propylene glycol 7.0 g Ethanol 10.0 g Methyl parahydroxybenzoate 0.05 g Perfume 0.05 g Purified water residue Was prepared as a skin cosmetic.
【0034】(効果試験) 〔ヒト表皮角化細胞増殖促進作用〕上記実施例1で得た
各種ハス胚芽抽出物について、以下の試験方法に基づい
て表皮角化細胞増殖促進作用を測定し、その結果を表2
に示す。なお、各試料溶液の溶媒である50v/v%DM
SO・水混液を用いて試験したコントロール値を100
として示す。 試験方法:正常ヒト新生児皮膚表皮角化細胞(NHE
K)を25cm2のフラスコ内で正常ヒト表皮角化細胞
用培地にて37℃、5%CO2環境下で培養し、常法に
より角化細胞を集めた。得られた角化細胞を同培地にて
2.5×104個/mlになるように調整し、200μl
ずつ48穴のプレートに播種し、5%CO 2環境下、3
7℃で一夜培養した。培養後、上記ハス胚芽抽出物を5
0v/v%DMSO・水混液に溶解した表2に示す濃度の
試料溶液2μlずつを添加し、37℃、5%CO2環境下
で3日間培養した。培養後、多田らによるMTT法(J.I
mmunol.Methods.93,157,1986)に従い、増殖作用を測定
した。(Effect test) [Human epidermal keratinocyte proliferation promoting effect] Obtained in Example 1 above
Based on the following test methods for various lotus germ extracts
The effect of promoting epidermal keratinocyte proliferation was measured by using
Shown in The solvent of each sample solution, 50 v / v% DM
The control value tested using the SO / water mixture was 100
As shown. Test method: Normal human neonatal skin epidermal keratinocytes (NHE)
K) 25cmTwoHuman epidermal keratinocytes in a flask
37 ° C, 5% COTwoCulture in an environment
More keratinocytes were collected. Obtain the keratinocytes in the same medium
2.5 × 10FourAnd adjust to 200 μl
Seeded into a 48-well plate at a time, 5% CO TwoUnder environment 3
Cultured overnight at 7 ° C. After culturing, the above lotus germ extract was
0 v / v% DMSO / water
Add 2 μl of sample solution at 37 ° C., 5% COTwoUnder the environment
For 3 days. After the culture, the MTT method by Tada et al. (J.I.
mmunol.Methods.93,157,1986)
did.
【0035】[0035]
【表2】 [Table 2]
【0036】表2から分かるように、本発明に係る表皮
角化細胞増殖促進剤には、良好なヒト表皮角化細胞増殖
促進作用があることが確認された。As can be seen from Table 2, it was confirmed that the agent for promoting the proliferation of keratinocytes according to the present invention has a good promoting action on the proliferation of human keratinocytes.
【0037】[0037]
【発明の効果】本発明によれば、安全性が高く、新規な
表皮角化細胞増殖促進剤を提供することができる。これ
を美容用食品や皮膚化粧料に応用することにより、皮膚
の新陳代謝を促進し、皮膚老化防止、細胞賦活及び創傷
治癒促進に大きく貢献することができる。According to the present invention, it is possible to provide a novel highly safe epidermal keratinocyte proliferation promoter. By applying this to cosmetic foods and skin cosmetics, the metabolism of the skin can be promoted, which can greatly contribute to the prevention of skin aging, cell activation, and promotion of wound healing.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 7/00 A61K 7/00 N M U A61P 17/02 A61P 17/02 17/16 17/16 A23L 2/00 F Fターム(参考) 4B014 GB06 GG17 GK12 4B017 LC03 LG15 LL09 LP01 4B018 LB01 LB08 LE01 LE02 LE05 MD61 ME14 MF01 MF08 4C083 AA032 AA072 AA082 AA111 AA112 AA122 AC022 AC072 AC102 AC122 AC182 AC242 AC302 AC422 AC442 AC482 AC642 AD042 AD112 AD332 AD412 AD512 AD532 AD642 AD662 CC02 CC04 CC05 CC07 DD23 DD31 DD41 EE10 EE12 EE13 4C088 AB39 AC04 BA08 NA14 ZA89──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61K 7/00 A61K 7/00 NMU A61P 17/02 A61P 17/02 17/16 17/16 A23L 2 / 00 FF term (reference) 4B014 GB06 GG17 GK12 4B017 LC03 LG15 LL09 LP01 4B018 LB01 LB08 LE01 LE02 LE05 MD61 ME14 MF01 MF08 4C083 AA032 AA072 AA082 AA111 AA112 AA122 AC022 AC072 AC102 AD122 AC412 AD482 AD532 AD642 AD662 CC02 CC04 CC05 CC07 DD23 DD31 DD41 EE10 EE12 EE13 4C088 AB39 AC04 BA08 NA14 ZA89
Claims (3)
する表皮角化細胞増殖促進剤。1. An agent for promoting proliferation of epidermal keratinocytes, which comprises a lotus germ extract.
を含有することを特徴とする美容用食品。2. A cosmetic food, comprising the epidermal keratinocyte proliferation promoter according to claim 1.
を含有することを特徴とする皮膚化粧料。3. A skin cosmetic comprising the epidermal keratinocyte proliferation promoter according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000260835A JP2002068993A (en) | 2000-08-30 | 2000-08-30 | Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000260835A JP2002068993A (en) | 2000-08-30 | 2000-08-30 | Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002068993A true JP2002068993A (en) | 2002-03-08 |
Family
ID=18748780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000260835A Pending JP2002068993A (en) | 2000-08-30 | 2000-08-30 | Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002068993A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004229611A (en) * | 2003-01-31 | 2004-08-19 | J-Oil Mills Inc | Anti-uv food composition |
JP2005002041A (en) * | 2003-06-11 | 2005-01-06 | Medi Cube Co Ltd | Water-soluble pearl powder |
WO2005042555A1 (en) * | 2003-10-30 | 2005-05-12 | Meiji Seika Kaisha, Ltd. | Tyrosinase activity inhibitor and ameliorant for facial blood flow |
JP2005298489A (en) * | 2004-03-15 | 2005-10-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
US7504117B2 (en) | 2003-08-28 | 2009-03-17 | Purimed Co., Ltd. | Extract of Nelumbinis Semen for the treatment of depression |
JP2010043088A (en) * | 2004-03-15 | 2010-02-25 | Kyoei Kagaku Kogyo Kk | Cosmetic product |
JP2010143884A (en) * | 2008-12-22 | 2010-07-01 | Shiseido Co Ltd | Chapped skin improving agent |
JP2012041276A (en) * | 2010-08-12 | 2012-03-01 | Maruzen Pharmaceut Co Ltd | Carbonylation inhibitor of protein, or transparency improver of skin |
WO2012147619A1 (en) * | 2011-04-27 | 2012-11-01 | キッコーマン株式会社 | Blood glucose level increase inhibitor |
JP2014105167A (en) * | 2012-11-26 | 2014-06-09 | Kyoei Kagaku Kogyo Kk | Cosmetic |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925348A (en) * | 1996-02-23 | 1999-07-20 | Medical Doctor's Research Institute, Inc. | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin |
CN1254755A (en) * | 1998-11-21 | 2000-05-31 | 乌鲁木齐恭喜酒厂 | Lotus seed wine and its production technology |
JP2002029980A (en) * | 2000-07-12 | 2002-01-29 | Maruzen Pharmaceut Co Ltd | Estrogenic agent and collagen production rpomoter, fibroblast proliferative agent, food for cosmetological use and skin cosmetic |
-
2000
- 2000-08-30 JP JP2000260835A patent/JP2002068993A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925348A (en) * | 1996-02-23 | 1999-07-20 | Medical Doctor's Research Institute, Inc. | Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin |
CN1254755A (en) * | 1998-11-21 | 2000-05-31 | 乌鲁木齐恭喜酒厂 | Lotus seed wine and its production technology |
JP2002029980A (en) * | 2000-07-12 | 2002-01-29 | Maruzen Pharmaceut Co Ltd | Estrogenic agent and collagen production rpomoter, fibroblast proliferative agent, food for cosmetological use and skin cosmetic |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004229611A (en) * | 2003-01-31 | 2004-08-19 | J-Oil Mills Inc | Anti-uv food composition |
JP2005002041A (en) * | 2003-06-11 | 2005-01-06 | Medi Cube Co Ltd | Water-soluble pearl powder |
US7504117B2 (en) | 2003-08-28 | 2009-03-17 | Purimed Co., Ltd. | Extract of Nelumbinis Semen for the treatment of depression |
WO2005042555A1 (en) * | 2003-10-30 | 2005-05-12 | Meiji Seika Kaisha, Ltd. | Tyrosinase activity inhibitor and ameliorant for facial blood flow |
US7863248B2 (en) | 2003-10-30 | 2011-01-04 | Meiji Seika Kaisha, Ltd. | Tyrosinase activity inhibitor and ameliorant for facial blood flow |
JP2005298489A (en) * | 2004-03-15 | 2005-10-27 | Kyoei Kagaku Kogyo Kk | Cosmetic |
JP2010043088A (en) * | 2004-03-15 | 2010-02-25 | Kyoei Kagaku Kogyo Kk | Cosmetic product |
JP4563225B2 (en) * | 2004-03-15 | 2010-10-13 | 共栄化学工業株式会社 | Cosmetics |
JP2010143884A (en) * | 2008-12-22 | 2010-07-01 | Shiseido Co Ltd | Chapped skin improving agent |
JP2012041276A (en) * | 2010-08-12 | 2012-03-01 | Maruzen Pharmaceut Co Ltd | Carbonylation inhibitor of protein, or transparency improver of skin |
WO2012147619A1 (en) * | 2011-04-27 | 2012-11-01 | キッコーマン株式会社 | Blood glucose level increase inhibitor |
JP2014105167A (en) * | 2012-11-26 | 2014-06-09 | Kyoei Kagaku Kogyo Kk | Cosmetic |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002029980A (en) | Estrogenic agent and collagen production rpomoter, fibroblast proliferative agent, food for cosmetological use and skin cosmetic | |
CN102781421B (en) | Extrait du fruit de schizandra sphenanthera et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant | |
JP4658348B2 (en) | Collagen production promoter, collagenase inhibitor, fibroblast proliferation agent, elastase inhibitor, estrogen-like agent, and skin cosmetics | |
KR101840508B1 (en) | Beautiful-skin-promoting agent and use thereof | |
JP4658290B2 (en) | Fibroblast proliferating agent, cosmetic food and drink, and skin cosmetics | |
JP2002003393A (en) | Fibroblast growth agent, food and drink for beauty culture and skin cosmetic | |
JP5617110B2 (en) | Oral hair growth promoter | |
JP2002068993A (en) | Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic | |
JP5027361B2 (en) | Hyaluronic acid production promoter | |
JP4889068B2 (en) | Histamine release inhibitor, cyclic AMP phosphodiesterase inhibitor, active oxygen scavenger and radical scavenger | |
JP2014105210A (en) | Composition containing white tea extract having activity of inhibiting skin crease formation and ameliorating crease | |
JP2015017067A (en) | Food products, cosmetics, pharmaceuticals, and animal feed for promoting hair growth or preventing and improving hair loss | |
JP2003137801A (en) | Collagen production promoter, collagenase inhibitor, fibroblast cell-propagating agent, skin cosmetic material and food or beverage for cosmetic use | |
JP5095893B2 (en) | Active oxygen scavenger | |
JP4722595B2 (en) | Anti-inflammatory agents, antioxidants and whitening agents, and skin cosmetics | |
JP2001316275A (en) | Collagen production promoter, estrogen-like agent, collagenase inhibitor, skin cosmetic, food and drink | |
JP6718158B2 (en) | Liver function improver | |
KR102032830B1 (en) | Fuctional food improving skin condition comprising rice bran extract | |
KR102106440B1 (en) | Composition for improving skin condition comprising blueberry and black rice extract fermented lactic acid bacteria | |
KR102212343B1 (en) | Composition for skin anti-aging or moisturization comprising extract of marian plum | |
JP2004149729A (en) | Antioxidant | |
JP2011032177A (en) | Inhibitor of kit cleavage | |
KR20170025363A (en) | Composition for improving skin | |
JP5362976B2 (en) | Blood flow improver | |
JP2004161678A (en) | Anti-inflammatory agent and cyclic amp phosphodiesterase inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070614 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20070614 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20071214 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100921 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101104 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A132 Effective date: 20101130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110125 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110215 |